click below
click below
Normal Size Small Size show me how
Blue Module
Blood, Lymph, and Immune- Rev. Defs
Term | Definition |
---|---|
hemophilia | A hereditary disorder in which there is an impairment of the blood clotting mechanism. |
hemoglobin | A specialized plasma protein containing iron which gives blood its red colour and also carries O2 to body tissues. |
immunocompetent | Ability to develop an immune response or recognize antigens and respond to them. |
edema | Abnormal accumulation of fluids in the intercellular spaces of the body. |
disseminated intravascular coagulation (DIC) | Abnormal activation of the proteins involved in blood coagulation, causing small blood colts to form in vessels and cutting off the supply of O2 to distal tissues. |
thrombocytopenia | Abnormal decrease in platelets caused by low production of platelets in the bone marrow or increased destruction of platelets in the blood vessels, spleen or liver. |
hemosiderosis | Abnormal increase of iron in the blood. |
leukocytosis | Abnormal increase of white cells. |
lymphadenopathy | Any disease of the lymph nodes. |
hemoglobinopathy | Any disorder caused by abnormalities in the hemoglobin molecule. |
immunotherapy | Any form of treatment that alters, enhances, stimulates or restores the body's natural immune mechanisms to treat disease. |
von Willebrand disease | Bleeding disorder caused by a deficiency of von Willebrand factor, a "sticky" protein that lines blood vessels and reacts with platelets to form a plug that leads to clot formation. |
antiserum | Blood serum that contains antibodies. |
megakaryocyte | Cell with a large nucleus; fragments become platelets. |
cytokine | Chemical substance produced by certain cells that initiates, inhibits, increases or decreases activity in other cells. |
pernicious anemia | Chronic, progressive anemia found mostly in people older than age 50 due to lack of sufficient vitamin B12 needed for blood cell development. |
blood | Composed of a liquid portion called plasma, and a solid portion containing RBCs, WBCs, and platelets. |
graft-versus-host disease (GVHD) | Complication that occurs following a stem cell or bone marrow transplant in which the transplant produces antibodies against recipient's organs that can be severe enough to cause death. |
phagocytosis | Condition of ingesting cells. |
leukopenia | Decrease in white blood cells. |
thrombocytopenia | Decrease of platelets. |
erythropenia | Decreased red blood cells. |
antimicrobials | Destroy bacteria, fungi, and protozoa, depending in the particular drug, generally by interfering with the functions of their cell membrane or their reproductive cycle. |
thrombolysis | Destruction of a clot. |
hemolytic anemia | Destruction of RBCs, commonly resulting in jaundice. |
erythrocytolysis | Destruction of red cells. |
dyspnea | Difficulty breathing. |
adenopathy | Disease of a gland. |
thrombolytics | Dissolve blood clots by destroying their fibrin strands. |
vertigo | Dizziness. |
myeloblast | Embryonic WBC formed in bone marrow. |
splenomegaly | Enlargement of the spleen. |
autoimmune disease | Failure of the body to accurately distinguish between what is "self" and what is "non-self" |
hematopoiesis | Formation of blood cells and platelets in the bone marrow. |
bone marrow magnetic resonance imaging | Highly sensitive imaging procedure that detects lesions and changes in bone tissue and bone marrow, especially in multiple myeloma. |
allergy injections | Injection with increasing strengths of the offending antigen given over a period of months or years to increase tolerance to an antigen responsible for severe allergies.. |
reticulocyte | Immature RBC. |
folic-acid deficiency anemia | Inability to produce sufficient red blood cells due to the lack of folic acid, a B vitamin essential for erythropoiesis. |
transfusion | Infusion of blood or blood products from one person to another. |
homologous bone marrow transplant | Infusion of bone marrow or stem cells from a compatible donor after a course of chemotherapy and/or radiation; also called allogenic transplant |
bone marrow transplant | Infusion of healthy bone marrow stem cells after the diseased bone marrow is destroyed by chemotherapy and/or radiation therapy; used to treat leukemia, aplastic anemia, and certain cancers. |
autologous bone marrow transplant | Infusion of the patient's own bone marrow or stem cells after a course of chemotherapy and/or radiation therapy. |
sickle cell anemia | Inherited anemia that causes RBCs to become crescent, or sickle-shaped when O2 levels are low. |
lymphoscintigraphy | Introduction of a radioactive tracer into the lymph channels to determine lymph flow, identify obstructions, and locate the sentinel node. |
iron-deficiency anemia | Lack of sufficient iron in RBCs. |
monocyte | Leukocyte that is phagocytic; has a large nucleus. |
eosinophil | Leukocyte that protects the body by releasing toxins to destroy harmful invaders. |
basophil | Leukocyte that releases histamines and heparin; slightly phagocytic. |
hematoma | Localized accumulation of blood, usually clotted, in an organ, space, or tissue due to a break in, or severing of a blood vessel. |
hypotension | Low blood pressure. |
multiple myeloma | Malignant tumour of plasma cells in the bone marrow. |
erythrocyte | Mature red blood cell. |
antifibrinolytics | Neutralize fibrinolytic chemicals in the mucous membranes of the mouth, nose, and urinary tract to prevent the breakdown of blood clots. |
monospot | Nonspecific rapid serological test for the presence of the heterophile antibody, which develops several days after infection by Epstien-Barr virus, the organism that caused infectious mononucleosis. |
phlebotomy | Obtaining blood for the purpose of testing. |
Immunologist | One who specializes in the study of protection. |
hypochromic | Pertaining to decreases of colour. |
thrombocyte | Platelet; initiates blood clotting. |
sepsis | Presence of bacteria or their toxins in the blood; also called septicemia or blood poisoning. |
fat-soluble vitamins | Prevent and treat bleeding disorders resulting from a lack of prothrombin, which is commonly caused by vitamin K deficiency. |
anticouagulants | Prevent blood clot formation by inhibiting the synthesis or inactivating one or more clotting factors. |
antivirals | Prevent replication of viruses within host cells. |
graft rejection | Process in which a recipient's immune system attacks a transplanted organ or tissue. |
antibody | Protective protein produced by B lymphocytes in response to the presence of a foreign substance called an antigen. |
tachycardia | Rapid heart beat. |
erythema | Redness of the skin. |
anemia | Reduction in the number of circulating red blood cells. |
bone marrow aspiration | Removal of a small sample of bone marrow using a thin aspirating needle for microscopic examination. |
lymphadenectomy | Removal of lymph nodes, especially in surgical procedures undertaken to remove malignant tissue. |
sentinel node excision | Removal of the first lymph node that receives drainage from cancer-containing areas and the one most likely to contain malignant cells. |
thymectomy | Removal/excision of the thymus gland. |
myeloid | Resembling bone marrow. |
complete blood count | Series of tests that includes hemoglobin; hematocrit; red and white blood cell counts; platelet count; and differential count; also called hemogram. |
aplastic (hypoplastic) anemia | Serious form of anemia associated with bone marrow failure and resulting in erythropenia, leukopenia, and thrombocytopenia. |
natural killer cells (NK) | Specialized lymphocytes that kill abnormal cells by releasing chemicals that destroy the cell membrane, causing its intercellular fluids to leak out. |
hemocytoblast | stem cell. from which other blood cells develop. |
antigen | Substance, recognized as harmful the the host, that stimulates formation of antibodies in an immunocompetent individual. |
bile pigment | Substances derived from the breakdown of hemoglobin and excreted by the liver. |
lymphedema | Swelling, primarily in a single arm or leg, due to an accumulation of lymph within tissues caused by obstruction or disease in the lymph vessels. |
partial thromboplastin time (PTT) | Test that measures the length of time it takes blood to clot to screen for deficiencies of some clotting factor; also called activated partial thromboplastin time. |
prothrombin time (PT) | Test that measures the time it takes for prothrombin to form a clot; also called pro time. |
blood culture | Test to determine the presence of pathogens in the bloodstream. |
Shilling test | Test used to diagnose pernicious anemia by determining if the body properly absorbs vitamin B12 through the digestive tract. |
antinuclear antibody (ANA) | Test to identify antibodies that attack the nucleus of the individual's own body cells. |
plasma | The liquid portion of blood where blood cells are suspended. |
neutrophil | The most numerous white cell, highly phagocytic. |
morphology | The study of shape. |
viscous | Thick, sticky. |
myeloid tissue | Tissue which resembles the myelocyte of bone marrow. |
lymphoma | Tumour of lymph tissue. |
granulocyte | Type of white blood cell containing granules; formed in the red bone marrow. |
agranulocyte | Type of white blood cell without granules. |
biological | Use of immune system stimulators to enhance the immune response in the treatment of certain forms of cancer, RA, and Crohn disease; also called biologic therapy or biotherapy. |
lymphangiography | Visualization of lymphatic channels and lymph nodes using a contrast medium to determine blockages or other pathologies of the lymph system. |
systemic lupus erythematosus (SLE) | Widespread autoimmune disease that may affect the skin, brain, kidneys, and joints and causes chronic inflammation; also called discoid lupus if symptoms are limited to the skin. |
lymphocytes | White blood cell in blood and lymphatic tissues; provides protection from bacteria. |
leukocyte | White blood cell; prevents invasion of foreign microorganisms. |
thrombocythemia | Overproduction of platelets, leading to thrombosis or bleeding disorders due to platelet malformations. |